ICON PLC
(NASDAQ: ICLR)
-0.02
-0.06%
| Exchange: | NASDAQ |
| Stock: | ICON plc (ADR) |
| Industry: | Biotechnology |
| Employees: | 9,500 |
| ICON public limited company (ICON), is a contract research organization (CRO), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs, which support all stages of the clinical development process, which include from compound selection to Phase I-IV clinical studies.Specific services offered by ICON Central Laboratories include sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. On February 28, 2012 the Company acquired PriceSpective LLC (PriceSpective). On February 15, 2012, the Company acquired BeijingWits Medical Limited (BeijingWits). On February 15, 2013 the Company acquired the clinical trial services division of Cross Country Healthcare Inc. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
